Cargando…
Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
BACKGROUND: Fibrinogen is a marker of systemic inflammation and may be important in the pathogenesis and progression of chronic obstructive pulmonary disease (COPD). METHODS: We used baseline data from Atherosclerosis Risk in Communities and Cardiovascular Health Studies to determine the relation be...
Autores principales: | Valvi, Deepa, Mannino, David M, Müllerova, Hana, Tal-Singer, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299546/ https://www.ncbi.nlm.nih.gov/pubmed/22419864 http://dx.doi.org/10.2147/COPD.S29892 |
Ejemplares similares
-
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
por: Duvoix, Annelyse, et al.
Publicado: (2013) -
Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient Survey
por: Mannino, David, et al.
Publicado: (2022) -
Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019) -
Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care
por: Müllerová, Hana, et al.
Publicado: (2014) -
Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD
por: Lonergan, Mike, et al.
Publicado: (2020)